Communiqués COSCIENS Biopharma Inc.

Actions

CSCI

CA22112H2000

Recherche biotechnologique et médicale

Temps Différé Toronto S.E. Autres places de cotation 19:14:08 16/07/2026			Varia. 5j.	Varia. 1 janv.
8,000 ^CAD	+0,38%		-32,20%	-6,10%

03/07	COSCIENS Biopharma finalise la modification de son capital social	MT
18/06	Cosciens Biopharma Inc. annonce la nomination de Peter H. Puccetti au poste de PDG permanent, à compter du 18 juin 2026	CI

Communiqués

06/07	COSCIENS Biopharma Inc. Completes Share Capital Amendment	AQ
03/07	COSCIENS Biopharma Inc. Completes Share Capital Amendment	GL
23/06	COSCIENS Biopharma Inc. Announces Details of Share Capital Amendment	GL
18/06	COSCIENS Biopharma Inc. Announces Results of Shareholder Meeting and Appointment of Full-Time CEO	GL
12/05	COSCIENS Biopharma: Q1 Earnings Snapshot	AQ
12/05	COSCIENS Biopharma Inc. Reports Q1 2026 Results	GL
20/04	COSCIENS Biopharma Inc. Provides Update on its Plan to Suspend U.S. Public Company Reporting Obligations	GL
07/04	COSCIENS Comments on Unusual Market Activity	GL
25/03	COSCIENS Biopharma: Q4 Earnings Snapshot	AQ
25/03	COSCIENS Biopharma Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update	GL
05/03	COSCIENS Provides Strategic Update	GL
01/12	COSCIENS Announces Exclusive Distribution Agreement with Wuzhou Drug International for Macrilen® in Hainan-Guangdong-Hong Kong-Macao Greater Bay Area and Singapore	GL
14/11	COSCIENS Biopharma Inc. Announces Leadership Change	GL
11/11	COSCIENS Biopharma: Q3 Earnings Snapshot	AQ
11/11	COSCIENS Biopharma Inc. Reports Third Quarter 2025 Financial Results and Provides Strategic Initiatives Update	GL
14/08/25	COSCIENS Biopharma: Q2 Earnings Snapshot	AQ
14/08/25	COSCIENS Biopharma Inc. Reports Second Quarter 2025 Financial Results and Provides Strategic Initiatives Update	GL
01/07/25	COSCIENS Biopharma Announces Results of Virtual 2025 Meeting of Shareholders	GL
30/05/25	COSCIENS Biopharma Inc. Reconstitutes Board for Benefit of Shareholders	GL
26/05/25	COSCIENS Biopharma Inc. Acknowledges Receipt of Intended Director Nominations from Goodwood for the Upcoming Annual and Special Meeting of Shareholders	GL
26/05/25	COSCIENS Biopharma Inc. Acknowledges Receipt of Intended Director Nominations from Goodwood for the Upcoming Annual and Special Meeting of Shareholders	AQ
23/05/25	Goodwood to Nominate New Directors for COSCIENS Biopharma Inc.	AQ
13/05/25	COSCIENS Biopharma: Q1 Earnings Snapshot	AQ
13/05/25	COSCIENS Biopharma Inc. Reports First Quarter 2025 Financial Results and Provides a Corporate Update	GL
13/05/25	COSCIENS Biopharma Inc. Reports First Quarter 2025 Financial Results and Provides a Corporate Update	AQ